Events

Does Anxiety Increase the Risk for, and Severity of, Conduct Problems Among Children with Co-Occurring ADHD?

As a practicing pediatric psychopharmacologist and clinical researcher, Dr Connor has extensive experience treating children, adolescents, and adults with Attention Deficit Hyperactivity Disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), anxiety disorder, and affective disorders. His research interests include investigating the effectiveness and tolerability of existing and new pharmacological treatments for PTSD, ADHD, ODD, and CD in children and adults, studying the phenomenology of impulsive-aggressive behaviors in psychiatric patients, and investigating the developmental neurobiology of aggression and externalizing behavior disorders.

Friday, May 12, 2017

9:00 am – 10:30 am

Add to Cal

Child Mind Institute

445 Park Avenue
New York, New York

Dr. Daniel Connor is Professor of Psychiatry and holds the Lockean Distinguished Chair in Mental Health Education, Research, and Clinical Improvement at the University of Connecticut Medical School. He is Division Chief of Child and Adolescent Psychiatry at the University of Connecticut Health Center in Farmington, CT. In 2013 he was selected as a Connecticut Child Health and Development Institute Senior Fellow. He is a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry. He is certified by the American Board of Psychiatry and Neurology in Adult Psychiatry, and subspecialty-certified in Child & Adolescent Psychiatry.  As a practicing pediatric psychopharmacologist and clinical researcher, Dr Connor has extensive experience treating children, adolescents, and adults with Attention Deficit Hyperactivity Disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), anxiety disorder, and affective disorders.  His research interests include investigating the effectiveness and tolerability of existing and new pharmacological treatments for PTSD, ADHD, ODD, and CD in children and adults, studying the phenomenology of impulsive-aggressive behaviors in psychiatric patients, and investigating the developmental neurobiology of aggression and externalizing behavior disorders. He is most interested in developing and investigating new models of collaborative clinical care in pediatric mental health.  Dr Connor has authored or co-authored over 175 journal articles, abstracts, and book chapters. He is the author of Aggression and Antisocial Behaviors in Children and Adolescents: Research and Treatment, published by the Guilford Press in New York in 2002, and translated into a Russian edition in 2005 and a Japanese edition in 2008.  He is the lead author of Pediatric Psychopharmacology Fast Facts, published by WW Norton in 2006.

For more information about the Visiting Professor Lecture Series, please contact Sara Wolcott at sara.wolcott@childmind.org. The lectures are free, but seating is limited.

CME Accreditation:  This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of Northwell Health and Child Mind Institute. Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy:  Northwell Health adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by Northwell Health for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.

Planner and Speaker’s Disclosures:  Drs. Koplewicz, Steingard and Young have nothing to disclose. Dr. Connor has nothing to disclose.

Recognition of Program Support:  There is no commercial support for this program.